New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
MicroRNA holds clues to why some mammals are cancer-prone

MicroRNA holds clues to why some mammals are cancer-prone

by Sheri Hall,Cornell UniversityCanine and equine mammosphere-derived epithelial cells (MDECs) respond differently to 7, 12-Dimethylbenz(a)anthracene (DMBA) and have distinct microRNA (miRNA) ex
Oncology December 20,2023
MicroRNA holds clues to why some mammals are cancer-prone

MicroRNA holds clues to why some mammals are cancer-prone

by Sheri Hall,Cornell UniversityCanine and equine mammosphere-derived epithelial cells (MDECs) respond differently to 7, 12-Dimethylbenz(a)anthracene (DMBA) and have distinct microRNA (miRNA) ex
Oncology December 20,2023
MicroRNA is the master regulator of the genome—researchers are learning how to harness the way it controls genes

MicroRNA is the master regulator of the genome—researchers are learning how to harness the way it controls genes

by Andrea Kasinski,The ConversationMicroRNA can silence genes by binding to mRNA. Credit:Kajsa Mollersen/Wikimedia Commons,CC BY-SAThe Earthformed 4.5 billion years ago, and li
Oncology December 20,2023
MicroRNA is the master regulator of the genome—researchers are learning how to harness the way it controls genes

MicroRNA is the master regulator of the genome—researchers are learning how to harness the way it controls genes

by Andrea Kasinski,The ConversationMicroRNA can silence genes by binding to mRNA. Credit:Kajsa Mollersen/Wikimedia Commons,CC BY-SAThe Earthformed 4.5 billion years ago, and li
Oncology December 20,2023
From vaccines to AI: New weapons in the fight against cancer

From vaccines to AI: New weapons in the fight against cancer

Credit: CC0 Public DomainCould humanity finally be gaining the upper hand in our age-old fight against cancer?Recent scientific and medical advances have added several new weapons to our arsenal, incl
Oncology December 19,2023
From vaccines to AI: New weapons in the fight against cancer

From vaccines to AI: New weapons in the fight against cancer

Credit: CC0 Public DomainCould humanity finally be gaining the upper hand in our age-old fight against cancer?Recent scientific and medical advances have added several new weapons to our arsenal, incl
Oncology December 19,2023
Overall cancer mortality continued to decline from 2019 to 2020

Overall cancer mortality continued to decline from 2019 to 2020

by Elana GotkineOverall cancer mortality is continuing to decline, according to a study published online Jan. 12 inCA: A Cancer Journal for Clinicians.Rebecca L. Siegel, M.P.H., from the America
Oncology December 19,2023
Overall cancer mortality continued to decline from 2019 to 2020

Overall cancer mortality continued to decline from 2019 to 2020

by Elana GotkineOverall cancer mortality is continuing to decline, according to a study published online Jan. 12 inCA: A Cancer Journal for Clinicians.Rebecca L. Siegel, M.P.H., from the America
Oncology December 19,2023
Women with elevated breast cancer risk could see mortality benefit from estrogen-blocking drugs

Women with elevated breast cancer risk could see mortality benefit from estrogen-blocking drugs

byGeorgetown University Medical CenterCredit: Unsplash/CC0 Public DomainWhile it has long been recognized that drugs that block the cancer-promoting activity of estrogen reduce risk of developin
Oncology December 19,2023
Women with elevated breast cancer risk could see mortality benefit from estrogen-blocking drugs

Women with elevated breast cancer risk could see mortality benefit from estrogen-blocking drugs

byGeorgetown University Medical CenterCredit: Unsplash/CC0 Public DomainWhile it has long been recognized that drugs that block the cancer-promoting activity of estrogen reduce risk of developin
Oncology December 19,2023
Innovative technology shows great promise against certain head and neck cancers

Innovative technology shows great promise against certain head and neck cancers

by Rachel Sauer,CU Anschutz Medical CampusCredit: Pixabay/CC0 Public DomainOver the past decade, human papillomavirus (HPV) has increasingly been identified as a significant cause of certain hea
Oncology December 19,2023
Innovative technology shows great promise against certain head and neck cancers

Innovative technology shows great promise against certain head and neck cancers

by Rachel Sauer,CU Anschutz Medical CampusCredit: Pixabay/CC0 Public DomainOver the past decade, human papillomavirus (HPV) has increasingly been identified as a significant cause of certain hea
Oncology December 19,2023
Preliminary data suggest that ROS1 inhibitor, NVL-520, is well-tolerated and active in non-small cell lung cancer

Preliminary data suggest that ROS1 inhibitor, NVL-520, is well-tolerated and active in non-small cell lung cancer

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainPreliminary data from a phase I clinical trial of a new drug called NVL-520 for patients with non-small ce
World medicine December 19,2023
Preliminary data suggest that ROS1 inhibitor, NVL-520, is well-tolerated and active in non-small cell lung cancer

Preliminary data suggest that ROS1 inhibitor, NVL-520, is well-tolerated and active in non-small cell lung cancer

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainPreliminary data from a phase I clinical trial of a new drug called NVL-520 for patients with non-small ce
World medicine December 19,2023
Dementia complicates cancer care, increasing risk of poorer clinical outcome and patient experience

Dementia complicates cancer care, increasing risk of poorer clinical outcome and patient experience

byRegenstrief InstituteCredit: Pixabay/CC0 Public DomainPre-existing dementia complicates cancer care and increases the risk of worse clinical outcomes and inferior patient experience, according
Oncology December 19,2023
Dementia complicates cancer care, increasing risk of poorer clinical outcome and patient experience

Dementia complicates cancer care, increasing risk of poorer clinical outcome and patient experience

byRegenstrief InstituteCredit: Pixabay/CC0 Public DomainPre-existing dementia complicates cancer care and increases the risk of worse clinical outcomes and inferior patient experience, according
Oncology December 19,2023
Ultrafine particles can change defense against lung cancer

Ultrafine particles can change defense against lung cancer

by Graciela Gutierrez,Baylor College of MedicinenCB accelerates NSCLC development and metastasis in mice. (A) Schematic diagram of nCB exposure in Pts4d/dmice. Three-month-old Pts4d/d&nbsp
Oncology December 19,2023
Ultrafine particles can change defense against lung cancer

Ultrafine particles can change defense against lung cancer

by Graciela Gutierrez,Baylor College of MedicinenCB accelerates NSCLC development and metastasis in mice. (A) Schematic diagram of nCB exposure in Pts4d/dmice. Three-month-old Pts4d/d&nbsp
Oncology December 19,2023
Ultrasound-guided surgery could be quicker, less painful and more effective for treating early form of breast cancer

Ultrasound-guided surgery could be quicker, less painful and more effective for treating early form of breast cancer

by European Organisation for Research and Treatment of CancerAntonio Esgueva using IOUS to guide breast surgery. Credit: Antonio Esguega / EORTCUsing ultrasound to guide surgery for patients with duct
Oncology December 19,2023
Ultrasound-guided surgery could be quicker, less painful and more effective for treating early form of breast cancer

Ultrasound-guided surgery could be quicker, less painful and more effective for treating early form of breast cancer

by European Organisation for Research and Treatment of CancerAntonio Esgueva using IOUS to guide breast surgery. Credit: Antonio Esguega / EORTCUsing ultrasound to guide surgery for patients with duct
Oncology December 19,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com